Literature DB >> 30172635

Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice.

Zhiguang Ren1, Yongkun Zhao2, Jing Liu3, Xianliang Ji2, Lingnan Meng2, Tiecheng Wang2, Weiyang Sun2, Kun Zhang2, Xiaoyu Sang2, Zhijun Yu2, Yuanguo Li2, Na Feng2, Hualei Wang2, Songtao Yang2, Zhengyan Yang4, Zhizeng Wang4, Yuwei Gao5, Xianzhu Xia6.   

Abstract

We previously demonstrated that intramuscular immunization with virus-like particles (VLPs) composed of the haemagglutinin (HA), neuraminidase (NA), and matrix (M1) proteins of A/meerkat/Shanghai/SH-1/2012 (clade 2.3.2.1) protected mice from lethal challenge with viruses from other H5 HPAI clades. The inclusion of additional proteins that can serve as immunological adjuvants in VLPs may enhance adaptive immune responses following vaccination, and oral vaccines may represent the safest choice. Here, we report the generation of H5N1 VLPs composed of the viral HA, NA, and M1 proteins and membrane-anchored forms of the Escherichia coli heat-labile enterotoxin B subunit protein (LTB) or the Toll-like receptor 5 ligand flagellin (Flic). Mice intramuscularly or orally immunized with VLPs containing LTB or Flic generated greater humoural and cellular immune responses than those administered H5N1 VLPs without LTB or Flic. Intramuscular immunization with VLPs protected mice from lethal challenge with homologous or heterologous H5N1 viruses irrespective of whether the VLPs additionally included LTB or Flic. In contrast, oral immunization of mice with LTB- or Flic-VLPs conferred substantial protection against lethal challenge with both homologous and heterologous H5N1 influenza viruses, whereas mice immunized orally with VLPs lacking LTB and Flic universally succumbed to infection. Mice immunized orally with LTB- or Flic-VLPs showed 10-fold higher virus-specific IgG titres than mice immunized with H5N1-VLPs lacking LTB or Flic. Collectively, these results indicate that the inclusion of immunostimulatory proteins, such as LTB and Flic, in VLP-based vaccines may represent a promising new approach for the control of current H5N1 HPAI outbreaks by eliciting higher humoural and cellular immune responses and conferring improved cross-clade protection.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chimeric VLPs; H5N1 influenza; Immunogenicity; Mucosally vaccinated; Oral immunization; Vaccine

Mesh:

Substances:

Year:  2018        PMID: 30172635     DOI: 10.1016/j.vaccine.2018.08.053

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice.

Authors:  Eun-Ju Ko; Youri Lee; Young-Tae Lee; Yu-Jin Jung; Vu L Ngo; Min-Chul Kim; Ki-Hye Kim; Bao-Zhong Wang; Andrew T Gewirtz; Sang-Moo Kang
Journal:  Vaccine       Date:  2019-05-14       Impact factor: 3.641

Review 2.  Demystifying particle-based oral vaccines.

Authors:  Pedro Gonzalez-Cruz; Harvinder Singh Gill
Journal:  Expert Opin Drug Deliv       Date:  2021-07-06       Impact factor: 8.129

3.  Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses.

Authors:  Joseph R Plummer; James P McGettigan
Journal:  PLoS Negl Trop Dis       Date:  2019-11-14

4.  Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins.

Authors:  Marianela C Serradell; Lucía L Rupil; Román A Martino; César G Prucca; Pedro G Carranza; Alicia Saura; Elmer A Fernández; Pablo R Gargantini; Albano H Tenaglia; Juan P Petiti; Renata R Tonelli; Nicolás Reinoso-Vizcaino; José Echenique; Luciana Berod; Eliane Piaggio; Bertrand Bellier; Tim Sparwasser; David Klatzmann; Hugo D Luján
Journal:  Nat Commun       Date:  2019-01-21       Impact factor: 14.919

Review 5.  Emerging Role of Mucosal Vaccine in Preventing Infection with Avian Influenza A Viruses.

Authors:  Tong Wang; Fanhua Wei; Jinhua Liu
Journal:  Viruses       Date:  2020-08-07       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.